FIELD: medical engineering. SUBSTANCE: method involves administering prospidine, thymaline and dibasol in combined mode. Thymaline is administered in parenteral way once a day at an age-oriented dose of 1-5 mg permissible according to the Pharmacopeia during 10 days. Dibasol is administered per os at a dose permissible according to the Pharmacopeia once a day during 13 days in the following mode. 0.004 g dose is given at the first-third day of treatment course and 0.002 g dose is given at the fourth-thirteenth day. Prospidine is administered in regional lymphotropic way in the area of sternocleidomastoid muscle once a day during 10 days at a dose of 0.1-0.2 g. EFFECT: enhanced effectiveness of treatment. 4 cl, 1 tbl
